cyproheptadine has been researched along with Diarrhea in 10 studies
Cyproheptadine: A serotonin antagonist and a histamine H1 blocker used as antipruritic, appetite stimulant, antiallergic, and for the post-gastrectomy dumping syndrome, etc.
cyproheptadine : The product resulting from the formal oxidative coupling of position 5 of 5H-dibenzo[a,d]cycloheptene with position 4 of 1-methylpiperidine resulting in the formation of a double bond between the two fragments. It is a sedating antihistamine with antimuscarinic and calcium-channel blocking actions. It is used (particularly as the hydrochloride sesquihydrate) for the relief of allergic conditions including rhinitis, conjunctivitis due to inhalant allergens and foods, urticaria and angioedema, and in pruritic skin disorders. Unlike other antihistamines, it is also a seratonin receptor antagonist, making it useful in conditions such as vascular headache and anorexia.
Diarrhea: An increased liquidity or decreased consistency of FECES, such as running stool. Fecal consistency is related to the ratio of water-holding capacity of insoluble solids to total water, rather than the amount of water present. Diarrhea is not hyperdefecation or increased fecal weight.
Excerpt | Relevance | Reference |
---|---|---|
"The potential role of endogenous opiates in the mediation of the diarrheal actions of prostaglandin-F2 alpha (PGF2 alpha), 5-hydroxytryptophan (5-HTP) and methacholine was investigated." | 7.66 | Naloxone reversal of drug-induced diarrhea in mice. ( Bertermann, RE; Dajani, EZ; Roge, EA; Schweingruber, FL; Woods, EM, 1979) |
" Treatment with cimetidine (H2 receptor antagonist) resulted in diarrhea, however, the addition of cyproheptadine (H1 receptor antagonist) was beneficial in amelioration of the cutaneous symptoms of mastocytosis." | 3.68 | Systemic mastocytosis treated with histamine H1 and H2 receptor antagonists. ( Falk, ES; Gasior-Chrzan, B, 1992) |
"The potential role of endogenous opiates in the mediation of the diarrheal actions of prostaglandin-F2 alpha (PGF2 alpha), 5-hydroxytryptophan (5-HTP) and methacholine was investigated." | 3.66 | Naloxone reversal of drug-induced diarrhea in mice. ( Bertermann, RE; Dajani, EZ; Roge, EA; Schweingruber, FL; Woods, EM, 1979) |
"Treatment with cyproheptadine caused a documented response in the patient's debilitating diarrhoea and also produced symptomatic improvement in her muscular power." | 1.25 | Carcinoid myopathy and treatment with cyproheptadine (Periactin). ( Berry, EM; Maunder, C; Wilson, M, 1974) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (70.00) | 18.7374 |
1990's | 1 (10.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (20.00) | 2.80 |
Authors | Studies |
---|---|
Costas, C | 2 |
Louzao, MC | 2 |
Raposo-García, S | 1 |
Vale, C | 2 |
Vieytes, MR | 2 |
Botana, LM | 2 |
Abal, P | 1 |
Suzuki, T | 1 |
Watanabe, R | 1 |
Vilariño, N | 1 |
Carrera, C | 1 |
Boente-Juncal, A | 1 |
Dajani, EZ | 1 |
Woods, EM | 1 |
Roge, EA | 1 |
Bertermann, RE | 1 |
Schweingruber, FL | 1 |
Gasior-Chrzan, B | 1 |
Falk, ES | 1 |
Orr, KB | 1 |
Harper, MJ | 1 |
Skarnes, RC | 1 |
Berry, EM | 1 |
Maunder, C | 1 |
Wilson, M | 1 |
Gillett, DJ | 1 |
Smith, RC | 1 |
Göschke, H | 1 |
Loong, SC | 1 |
Lance, JW | 1 |
Rawle, KC | 1 |
10 other studies available for cyproheptadine and Diarrhea
Article | Year |
---|---|
Intestinal secretory mechanisms in Okadaic acid induced diarrhoea.
Topics: Animals; Chlorides; Cyproheptadine; Diarrhea; Jejunum; Mice; Okadaic Acid; Phosphoprotein Phosphatas | 2022 |
Serotonin involvement in okadaic acid-induced diarrhoea in vivo.
Topics: Animals; Cyproheptadine; Diarrhea; Enzyme Inhibitors; Female; Mice; Neuropeptide Y; Okadaic Acid; Pe | 2021 |
Naloxone reversal of drug-induced diarrhea in mice.
Topics: 5-Hydroxytryptophan; Animals; Antidiarrheals; Cyproheptadine; Diarrhea; Dose-Response Relationship, | 1979 |
Systemic mastocytosis treated with histamine H1 and H2 receptor antagonists.
Topics: Biopsy; Cimetidine; Colon; Cyproheptadine; Diarrhea; Drug Therapy, Combination; Humans; Liver; Male; | 1992 |
The carcinoid syndrome: An example due to an ileal polyp.
Topics: Autopsy; Carcinoid Tumor; Cyanosis; Cyproheptadine; Diarrhea; Female; Humans; Hydroxyindoleacetic Ac | 1970 |
Inhibition of abortion and fetal death produced by endotoxin or prostaglandin F2alpha.
Topics: Abortion, Induced; Abortion, Threatened; Animals; Cyproheptadine; Diarrhea; Endotoxins; Female; Feta | 1972 |
Carcinoid myopathy and treatment with cyproheptadine (Periactin).
Topics: Acid Phosphatase; Cyproheptadine; Diarrhea; Feces; Female; Fenclonine; Humans; Hydroxyindoleacetic A | 1974 |
Treatment of the carcinoid syndrome by hemihepatectomy and radical excision of the primary lesion.
Topics: Aged; Cyproheptadine; Diarrhea; Fenclonine; Heart Valve Diseases; Hepatectomy; Humans; Hydroxyindole | 1974 |
[Drug therapy of the carcinoid syndrome].
Topics: Asthma; Carcinoid Tumor; Chlorpromazine; Cyclophosphamide; Cyproheptadine; Diarrhea; Humans; Methyse | 1968 |
The control of flushing and diarrhoea in carcinoid syndrome by an antiserotonin agent, BC105.
Topics: Blood Circulation; Chloramphenicol; Cyproheptadine; Diarrhea; Face; Humans; Hyperemia; Ileum; Liver | 1968 |